France Approves AstraZeneca’s COVID-19 Vaccine But Restricts Its Usage For Patients Aged Above 65

Earlier this week, the European Medicines Agency (EMA) gave its approval to AstraZeneca. The news came out as a relief for the French Government, whose vaccination campaign was highly criticized for its slow pace.

ZEE5 Web Desk

February 4, 2021

Trending News

2 min

zeenews

On Tuesday, France health regulators approved the use of AstraZeneca’s COVID-19 vaccine while also stating that the vaccine cannot be given to people aged above 65. The Haute Autorite de la Sante also revealed that people aged 50 to 65 with health issues and medical staff will be given emergency access for the vaccination. After BioNTech and Moderna, AstraZeneca will be the third vaccine to be used in the nation’s battle against the pandemic.

Due to the lack of data for patients above the age of 65, the use of the AstraZeneca vaccine is restricted for them as of now. Dominique Le Guludec, the head of the health advisory said, “There is still insufficient data for those aged 65+. We hope to have them in the coming weeks.” Talking about the vaccine’s efficiency, she also added, “The vaccine’s performance is satisfactory with a 62%-70% efficacy depending on various study outcomes.”

Earlier this week, the European Medicines Agency (EMA) gave its approval to AstraZeneca. The news came out as a relief for the French Government, whose vaccination campaign was highly criticized for its slow pace. As of now, around one million doses have been administered in France.

The HAS stated that it expects France to get 10 million doses of the AstraZeneca vaccine in the coming three months, which would allow 5 million citizens to get vaccinated, given its two-dose model.

Meanwhile, stay tuned to ZEE5 for more updates.

 

ബന്ധപ്പെട്ട വിഷയങ്ങൾ

അനുബന്ധ വാർത്തകൾ

More Loader